Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuki Ando

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Oncology|November 1, 2021
Fanconi Anemia Complementation Group E, a DNA Repair-Related Gene, Is a Potential Marker of Poor Prognosis in Hepatocellular CarcinomaJunichi Takahashi, Takaaki Masuda, Akihiro Kitagawa, et al.
Anticancer Research|July 5, 2020
The Expression Level of <i>PD-L1</i> (<i>CD274</i>) mRNA in Peripheral Blood Is a Potential Biomarker for Predicting Recurrence in Breast CancerTakaaki Masuda, Miwa Noda, Akihiro Kitagawa, et al.
Surgery Today|December 22, 2025
Identification of the novel therapeutic target gene SLC12A9, which determines the prognosis of patients with colorectal cancerYusuke Yonemura, Takashi Ofuchi, Takafumi Nakano, et al.
American Heart Journal|October 8, 2013
Learning from recent trials and shaping the future of acute heart failure trialsRobert J Mentz, Gary Michael Felker, Tariq Ahmad, et al.
Cancer Science|January 7, 2026
PSMD12 Overexpression Promotes Lung Adenocarcinoma Progression via Ubiquitin-Proteasome Pathway DysregulationYuya Ono, Hajime Otsu, Takaaki Masuda, et al.
Cancer Genomics & Proteomics|March 4, 2023
Dynamic Changes in Peripheral Systemic Immunity Markers During Chemotherapy in HER2-negative Advanced Breast CancerTakaaki Masuda, Hiroaki Ueo, Yuta Okumura, et al.
International Cancer Conference Journal|August 14, 2023
Successful multidisciplinary treatment with complete response to atezolizumab plus bevacizumab in a 90-year-old patient with hepatocellular carcinoma recurrenceKiyotaka Hosoda, Takeo Toshima, Junichi Takahashi, et al.
Frontiers in Allergy|April 1, 2025
Real-life effectiveness of once-daily single-inhaler triple therapy (FF-UMEC-VI) after switching from dual therapy (ICS-LABA) in patients with symptomatic asthma: trelegy ellipta for real asthma control studyYoshitomo Kushima, Yasuo Shimizu, Ryo Arai, et al.
Cancer Science|June 19, 2025
Polarity Gene PARD6B Promotes Tumor Growth of Colorectal Cancer via Increasing MYC ExpressionKosuke Hirose, Takaaki Masuda, Hajime Otsu, et al.
Archives of Internal Medicine|August 21, 2012
A randomized, placebo-controlled trial of acupuncture in patients with chronic obstructive pulmonary disease (COPD): the COPD-acupuncture trial (CAT)Masao Suzuki, Shigeo Muro, Yuki Ando, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Oncology|November 1, 2021
Fanconi Anemia Complementation Group E, a DNA Repair-Related Gene, Is a Potential Marker of Poor Prognosis in Hepatocellular CarcinomaJunichi Takahashi, Takaaki Masuda, Akihiro Kitagawa, et al.
Anticancer Research|July 5, 2020
The Expression Level of <i>PD-L1</i> (<i>CD274</i>) mRNA in Peripheral Blood Is a Potential Biomarker for Predicting Recurrence in Breast CancerTakaaki Masuda, Miwa Noda, Akihiro Kitagawa, et al.
Surgery Today|December 22, 2025
Identification of the novel therapeutic target gene SLC12A9, which determines the prognosis of patients with colorectal cancerYusuke Yonemura, Takashi Ofuchi, Takafumi Nakano, et al.
American Heart Journal|October 8, 2013
Learning from recent trials and shaping the future of acute heart failure trialsRobert J Mentz, Gary Michael Felker, Tariq Ahmad, et al.
Cancer Science|January 7, 2026
PSMD12 Overexpression Promotes Lung Adenocarcinoma Progression via Ubiquitin-Proteasome Pathway DysregulationYuya Ono, Hajime Otsu, Takaaki Masuda, et al.
Cancer Genomics & Proteomics|March 4, 2023
Dynamic Changes in Peripheral Systemic Immunity Markers During Chemotherapy in HER2-negative Advanced Breast CancerTakaaki Masuda, Hiroaki Ueo, Yuta Okumura, et al.
International Cancer Conference Journal|August 14, 2023
Successful multidisciplinary treatment with complete response to atezolizumab plus bevacizumab in a 90-year-old patient with hepatocellular carcinoma recurrenceKiyotaka Hosoda, Takeo Toshima, Junichi Takahashi, et al.
Frontiers in Allergy|April 1, 2025
Real-life effectiveness of once-daily single-inhaler triple therapy (FF-UMEC-VI) after switching from dual therapy (ICS-LABA) in patients with symptomatic asthma: trelegy ellipta for real asthma control studyYoshitomo Kushima, Yasuo Shimizu, Ryo Arai, et al.
Cancer Science|June 19, 2025
Polarity Gene PARD6B Promotes Tumor Growth of Colorectal Cancer via Increasing MYC ExpressionKosuke Hirose, Takaaki Masuda, Hajime Otsu, et al.
Archives of Internal Medicine|August 21, 2012
A randomized, placebo-controlled trial of acupuncture in patients with chronic obstructive pulmonary disease (COPD): the COPD-acupuncture trial (CAT)Masao Suzuki, Shigeo Muro, Yuki Ando, et al.
Pageof 7